UGenome Mission Statement
To accelerate the benefits of genomic medicine for patients and healthcare professionals through clinically actionable insights.
UGenome Vision Statement
To make genomic medicine personal and accessible for everyone.
1. Curiosity. Learners & Teachers.
We learn with joy and respect for the complexities of understanding new phenomena. We enjoy sharing and focusing on our audience’s needs. As a community of learners and teachers, we encourage teamwork and open communication so people feel free to take risks and make mistakes to effectively leverage our diverse skill sets, talents, and experiences.
2. Empathy. Respect for your complicated lives
We respect that UGenome people, the people we will serve (clients), and the people facing health challenges (often referred to as patients) have complicated lives. If you need time to take care of yourself, then take it. We trust when you feel good, you’ll get back to life and UGenome projects.
Trust for us means being honest and transparent with what we believe our capacities are, then delivering on the goals for the project for the clients to give people better healthcare options. We believe in constructive candor. We value open and honest communication, embracing diverse opinions and constructive feedback to drive problem-solving and growth.
We celebrate diversity in people and perspectives. This has a two-fold benefit. First, we respect the diversity in people as a matter of principle and practice. Organizations that involve more varied voices are more productive. Second, we advocate for diversity in data. Diverse representation of the real-world population in data can help reduce bias in data-driven generation of hypotheses and results while improving the robustness and generalizability of actionable insights.
We embrace change as an opportunity for growth. We welcome continuous improvement (Kaizen) and strive to ensure our services and products meet the ever-evolving needs of our customers, healthcare practitioners, and patients.
We innovate for patient and customer impact. Being innovative isn’t a buzzword. It’s the act of pioneering solutions to complex problems, cultivating curiosity to embrace the unknown and try something new, and fostering a collaborative environment to ultimately learn and help others.
Most people and groups of people (organizations) can provide a good service once. Excellence is repeatedly providing high-quality services and products. We commit to upholding rigorous and high standards in delivering high-quality work and creating best-in-class tools/products.
Co-founder & CEO
In his previous role, Zachary helped lead the transition from Botanisol being primarily an R&D company — developing relationships with governmental agencies, academic institutions, and private companies and writing grant proposals for DOD, NSF, NIH, DARPA, IARPA – to being a product- and customer-first company. While completing his PhD graduating from both the Colleges of Science and Humanities at the University of Arizona, he served the four-term Graduate Student Body President raising $500,000 to launch graduate-student incubator and accelerator programs with the campus commercialization office (Tech Launch Arizona). Dr. Brooks is a #1 best selling Amazon author (“Discovering Your Human Algorithm”), President of World Transplant Athletes, Flinn-Brown Fellow (2017), founder of World Transplant Athletes, and 2021 Comeback-Giveback Awardee of the Chris Klug Foundation.
Zachary speaks English, German, Spanish, Portuguese, and he is developing high-level competence in French and Russian which he uses to develop customers in all continents. He continues to publish and lecture on “Bilingual Decision Making” combining decision sciences, psychology, and applied linguistics.
Chief Genomics Officer
Jayden received his PharmD degree from the University of Connecticut in 2011. He then completed a specialty pharmacy residency focusing on primary care pharmacy practice at Burgdorf Health Center in Hartford, CT. For his residency project, he focused on interprofessional practice and layered learning, collaborating with the chief medical resident and his team. After the residency, he worked as the clinic supervisor at Backus Medication Management Clinic in Norwich, CT, where he created and implemented medication therapy management and direct oral anticoagulant management services. Jayden then joined the Philadelphia College of Osteopathic Medicine in Suwanee, GA, as an assistant professor in the pharmacy practice department. During this time, he provided medication management services at Northeast Georgia Physicians Group in Braselton, GA. As a faculty member, he conducted original survey studies, retrospective observational studies, systematic reviews, and meta-analyses, which led to peer-reviewed publications. In his previous position as an ambulatory clinical pharmacist at Banner Health, he participated in the value-based care transformation, working with providers and patients to improve Star Rating measures, statin gap closures, and adherence rates for triple-weighted drugs.
Following his passion for medication optimization, Jayden has taken the role of Clinical Pharmacogenomics Director at UGenome to focus on pharmacogenomics and personalized medicine to provide medication optimization for patients.
Chief Product Officer
Peter has helped build multiple high-growth biomedical businesses, commercializing innovative products for surgery, diagnostics and digital treatment pathways in multiple international markets and leading R&D, regulated product development and strategic business development.
He founded Romilly Life Sciences to help health, tech and pharma organizations implement evidence-led digital product strategy, including technologies such as artificial intelligence, supported by effective cross-sector collaboration frameworks and coaching.
He is also co-founder of Migration Biotherapeutics, Honorary Professor at the University of Birmingham Centre for Regulatory Science and Innovation, Fellow and Chair of Healthcare at the Institution of Engineering and Technology, an Academy of Medical Sciences Future Leader in Innovation Enterprise and Research (FLIER) and works with HDRUK and NIHR to support leadership development and R&D funding programmes.
Bioinformatics advisor (38 years experience)
Business advisor (Saas, software development)
Science advisor (gene editing & drug development)
Randall S. Stafford, MD, PhD is a Professor of Medicine in the Stanford University School of
Medicine where he directs the Program on Prevention Outcomes and Practices (PPOP). His
training includes an MHS in Health Administration from Johns Hopkins, a PhD in Epidemiology
from UC Berkeley, an MD from UC San Francisco with clinical training in Primary Care
Internal Medicine at Massachusetts General Hospital. Dr. Stafford’s interests include: a)
improving the quality of outpatient disease management care, b) facilitating improved patient-
provider communication via new information technology, c) health disparities by race, gender,
age, and social status, and d) policies to reverse global patterns of obesity and chronic disease.
He has designed and tested interventions to improve health care for atrial fibrillation, weight
management, depression/anxiety, diabetes prevention, pain management, and cardiovascular
disease risk factors. For these project, Dr. Stafford received funding from NIH, NSF, AHRQ,
PCORI, the American Heart Association, and the American Diabetes Associates. As a research
mentor, Professor Stafford is training the next generation of researchers capable of transforming
health care. His work as a primary care physician focuses on chronic disease, prevention, and
health behaviors. He takes to heart the advice he provides to his patients with an ongoing personal
commitment to healthy eating, frequent physical activity, adequate sleep, stress-reduction strategies, and maintaining social connections.
Mental Health Medication Advisor
Global Healthcare Advisor
As a foreign émigré clinician and informaticist, Bryan is a seasoned global healthcare leader, lifestyle medicine practitioner, and entrepreneur with a focus on optimal health and motivating populations to be the best they can be in every aspect of their work and life. Bryan is also principal of a private holdings firm with a syndicated portfolio encompassing six industries. He loves building organisations that have a positive impact on the world and supporting others who are doing the same. Bryan’s main interest lies at the crossroads of combining medicine, exponential technologies, neuroscience, and entrepreneurial leadership to help solve real world problems that create greater life for all. Bryan is a passionate advocate for Global Health Care Equivalency (GHCE) which is an initiative that envisions a future of health where sickness is optional and all individuals on the planet have access to the same advanced and cost-effective nanomedical diagnostic and therapeutic technologies regardless of their condition or where they live. In his current project, Bryan is exploring the neurobiological origins of human behaviour and adaptation as a contributing author of two upcoming books, “Nanotechnology, Nanomedicine, and AI: Toward the Dream of Global Health Care Equivalency” and “Molecular Manufacturing: Emergence of the Grand Equalizer.”
Additionally, Bryan is an international advocate for youth and has trained with the Children’s Defence Fund’s Ella Baker Child Policy Institute which has resulted in the culmination of numerous youth advocacy service projects promoting learning, development, and healthy lifestyles for disenfranchised youth populations.